ArticleInternational journal of oncology2023

Anti‑PD‑1/PD‑L1 and anti‑CTLA‑4 associated checkpoint inhibitor pneumonitis in non‑small cell lung cancer: Occurrence, pathogenesis and risk factors (Review).

Xiao Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.